{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:23Z","timestamp":1790726423718,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02724","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:27:24Z","timestamp":1787182044000},"page":"e02724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emergence of a novel NDM-4-producing Citrobacter freundii complex species in a complicated urinary tract infection treated with cefiderocol"],"prefix":"10.1016","volume":"45","author":[{"given":"Cheyanne","family":"Boehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanis C.","family":"Dingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Croxen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarah","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-8099","authenticated-orcid":false,"given":"Deirdre","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02724_bib1","article-title":"Cefiderocol for the treatment of multidrug-resistant gram-negative bacteria: a systematic review of currently available evidence","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02724_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nwh.2020.07.006","article-title":"Cefiderocol for infections caused by multidrug-resistant gram-negative bacteria","volume":"24","author":"Weaver","year":"2020","journal-title":"Nurs Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106376","article-title":"Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID","volume":"90","author":"Soueges","year":"2025","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-023-01146-5","article-title":"Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence","volume":"13","author":"Viale","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-020-00286-6","article-title":"Cefiderocol: a novel agent for the management of multidrug-resistant gram-negative organisms","volume":"9","author":"Wu","year":"2020","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02724_bib6","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s15010-025-02584-y","article-title":"Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study","volume":"53","author":"Dickstein","year":"2025","journal-title":"Infection"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02724_bib7","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/jac\/dkad200","article-title":"vitro activity of cefiderocol against metallo-\u03b2-lactamase-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014\u20132019)","volume":"78","author":"Kohira","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib8","first-page":"e00910","article-title":"Cefiderocol for treatment of complicated urinary tract infections due to carbapenem-resistant pathogens: case series","volume":"65","author":"Stevens","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib9","first-page":"e3341","article-title":"Cefiderocol for treatment of complicated urinary tract infections due to carbapenem-resistant pathogens: case series","volume":"73","author":"Shields","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib10","article-title":"The Difficult-to-treat carbapenemase-producing Enterobacterales","volume":"7","author":"Nordmann","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.idcr.2026.e02724_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02724_bib12","first-page":"879","article-title":"Risk factors for infection with NDM-producing Enterobacterales","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.idcr.2026.e02724_bib13","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1093\/bioinformatics\/btac672","article-title":"GTDB-Tk v2: memory friendly classification with the genome taxonomy database","volume":"38","author":"Chaumeil","year":"2022","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.idcr.2026.e02724_bib14","doi-asserted-by":"crossref","first-page":"D743","DOI":"10.1093\/nar\/gkaf1040","article-title":"GTDB release 10: a complete and systematic taxonomy for 715 230 bacterial and 17 245 archaeal genomes","volume":"54","author":"Parks","year":"2026","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02724_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02724_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/mdr.2022.0279","article-title":"Vitro activity of cefiderocol against meropenem-nonsusceptible gram-negative Bacilli with defined beta-lactamase carriage: SIDERO-WT Surveillance Studies, 2014-2019","volume":"29","author":"Wise","year":"2023","journal-title":"Microb Drug Resist"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02724_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2018.10.007","volume":"53","author":"Kazmierczak","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02724_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01968-17","article-title":"Vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of gram-negative Bacilli collected worldwide in 2014\u20132016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib19","first-page":"S220","article-title":"Siderophore cephalosporins: cefiderocol mechanism of action","volume":"67","author":"Ito","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02724_bib20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JCM.00162-14","article-title":"Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years","volume":"52","author":"Peirano","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02724_bib21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/AAC.02661-15","article-title":"Molecular characterization by using next-generation sequencing of plasmids containing blaNDM-7 in Enterobacteriaceae from Calgary, Canada","volume":"60","author":"Chen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02724_bib22","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1128\/AAC.05961-11","article-title":"NDM-4 metallo-\u03b2-lactamase with increased carbapenemase activity from Escherichia coli","volume":"56","author":"Nordmann","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02724_bib23","first-page":"2126","article-title":"Oral vancomycin prophylaxis against recurrent Clostridium difficile infection in patients receiving systemic antimicrobial therapy","volume":"70","author":"Zacharioudakis","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02724_bib24","unstructured":"Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. M100-32, Wayne, PA USA: CLSI; 2022."},{"key":"10.1016\/j.idcr.2026.e02724_bib25","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). www.eucast.org."},{"issue":"3","key":"10.1016\/j.idcr.2026.e02724_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00103-22","article-title":"Rapid, high-throughput, cost-effective whole-genome sequencing of SARS-CoV-2 using a condensed library preparation of the Illumina DNA Prep kit","volume":"62","author":"Hickman","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02724_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad311","article-title":"NanoPacks2: population-scale evaluation of long-read sequencing data","volume":"39","author":"de Coster","year":"2023","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02724_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf474","article-title":"Autocycler: long-read consensus assembly for bacterial genomes","volume":"41","author":"Wick","year":"2025","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02724_bib29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-019-0072-8","article-title":"Assembly of long, error-prone reads using repeat graphs","volume":"37","author":"Kolmogorov","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02724_bib30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41587-023-01983-6","article-title":"High-quality metagenome assembly from long accurate reads with metaMDBG","volume":"42","author":"Benoit","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-024-03252-4","article-title":"NextDenovo: an efficient error correction and accurate assembly tool for noisy long reads","volume":"25","author":"Hu","year":"2024","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.idcr.2026.e02724_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad409","article-title":"Plassembler: an automated bacterial plasmid assembly tool","volume":"39","author":"Bouras","year":"2023","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009802","article-title":"Polypolish: short-read polishing of long-read bacterial genome assemblies","volume":"18","author":"Wick","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02724_bib34","article-title":"How low can you go? short-read polishing of oxford nanopore bacterial genome assemblies","volume":"10","author":"Bouras","year":"2024","journal-title":"Microb Genom"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02724_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007981","article-title":"The genome polishing tool POLCA makes fast and accurate corrections in genome assemblies","volume":"16","author":"Zimin","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"17","key":"10.1016\/j.idcr.2026.e02724_bib36","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"93","key":"10.1016\/j.idcr.2026.e02724_bib37","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.21105\/joss.05968","article-title":"Dnaapler: a tool to reorient circular microbial genomes","volume":"9","author":"Bouras","year":"2024","journal-title":"J Open Source Softw"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91456-0","article-title":"AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence","volume":"11","author":"Feldgarden","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02724_bib39","article-title":"Universal whole-sequence-based plasmid typing and its utility to prediction of host range and epidemiological surveillance","volume":"6","author":"Robertson","year":"2020","journal-title":"Microb Genom"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02724_bib40","article-title":"MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies","volume":"4","author":"Robertson","year":"2018","journal-title":"Microb Genom"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02724_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13059-016-0997-x","article-title":"Mash: fast genome and metagenome distance estimation using MinHash","volume":"17","author":"Ondov","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02724_bib42","first-page":"406","article-title":"The neighbor-joining method: a new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol Biol Evol"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02724_bib43","article-title":"Gotree\/Goalign: toolkit and Go API to facilitate the development of phylogenetic workflows","volume":"3","author":"Lemoine","year":"2021","journal-title":"NAR Genom Bioinform"},{"key":"10.1016\/j.idcr.2026.e02724_bib44","article-title":"Interplay between the catalytic activity of metallo-\u03b2-lactamases and the antibacterial activity of cefiderocol","author":"Potron","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib45","first-page":"e00912","article-title":"Characterization of the novel NDM-35-producing Escherichia coli highly resistant to \u03b2-lactams including cefiderocol","volume":"66","author":"Alm","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02724_bib46","first-page":"e00144","article-title":"An NDM-producing Escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward pan-\u03b2-lactam resistance","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02724_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03223-23","article-title":"When the Trojan horse is unable to reach inside the city: investigation of the mechanism of resistance behind the first reported cefiderocol-resistant Escherichia coli in Canada","volume":"12","author":"Barker","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02724_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(25)00469-4","article-title":"GAME CHANGER Trial Investigators. Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial","volume":"26","author":"Paterson","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02724_bib49","unstructured":"FDA prescribing information for EMBLAVEO (aztreonam and avibactam). U.S. Food and Drug Administration. 2025."},{"key":"10.1016\/j.idcr.2026.e02724_bib50","unstructured":"FDA Novel Drug Approvals 2026: Zaynich (cefepime and zidebactam). U.S. Food and Drug Administration. 2026."},{"key":"10.1016\/j.idcr.2026.e02724_bib51","article-title":"Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-\u03b2-lactamase-producing Enterobacterales","volume":"69","author":"Castanheira","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idcr.2026.e02724_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-20","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant gram-negative bacteria","volume":"64","author":"Mushtaq","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02724_bib53","first-page":"e134","article-title":"NDM-producing Citrobacter species in healthcare settings","volume":"75","author":"Sherry","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02724_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00366-23","article-title":"Nationwide molecular epidemiology of carbapenemase-producing Citrobacter spp. in France in 2019 and 2020","volume":"8","author":"Biez","year":"2023","journal-title":"mSphere"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02724_bib55","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jac\/dkac005","article-title":"Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France","volume":"77","author":"Biez","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:24Z","timestamp":1790723604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":55,"alternative-id":["S2214250926002374"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02724","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of a novel NDM-4-producing Citrobacter freundii complex species in a complicated urinary tract infection treated with cefiderocol","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02724"}}